A practical protocol to obtain accurate heat capacity values of pharmaceutical compounds using modulated-temperature differential scanning calorimetry was established. Three pharmaceutical compounds, acetaminophen, indomethacin, and tri-O-methyl-β-cyclodextrin were used as model compounds. Powder samples did not produce reproducible results, presumably due to inclusion of gas in gap of powders that influenced the measured heat capacity and thermal homogeneity in the sample. Thus, the amorphous characteristics were evaluated using quench-cooled samples. Crystalline samples were obtained by partially melting the sample to allow recrystallization using the residual crystal as a template. Optimum sample mass was about 10 mg. Use of too small sample size resulted in poor reproducibility due to localization of the sample in the pan, while too large size resulted in low heat capacity values probably because of heterogeneity of the sample temperature. The optimum modulation period was in the range of 60 s and 90 s, to which the ramp rates of 2°C/min and 1°C/min, respectively, were applied. The ramp amplitude was less significant in the evaluation. This information should help in comprehending basic characteristics of pharmaceutical compounds.
However, there are still some unsolved problems for common use of amorphous formulations. Physical stability of the amorphous state is difficult to assure, since the crystallization rate under storage conditions cannot be predicted from accelerated stability studies. 1, 3, 4) Although the stability of the amorphous state can be improved by adding a large amount of excipients, intrinsic characteristics of the amorphous drugs must be understood well for the formulation design. Factors that influence the glass-forming ability 5, 6) of compounds have been of great interest from that viewpoint. Although one suggestion is that it is correlated with fragility, 7) no clear relationship has been presented so far. This is partially because the fragility values themselves are questionable in some papers, since precise determination of the heat capacity values, which is required for calculation of the fragility, is difficult.
Although reliable measurements of heat capacity can be performed using adiabatic calorimeters, more convenient methods are required from a practical point of view. Many efforts have been made to use modulated-temperature differential scanning calorimetry (MTDSC) as a tool for assessing the heat capacity in a simple procedure. [8] [9] [10] [11] [12] [13] However, discussions on this matter have been concentrated on theoretical aspects, and the experiments have usually been performed using single crystals or film samples that can offer relatively good thermal contact and temperature homogeneity in the samples. The melt-quench procedure is recognized as effective for obtaining amorphous samples for accurate heat capacity measurements. 11, 13) However, no guidance for measuring polycrystalline powder samples has been provided, despite its practical importance in pharmaceutical industry. As a matter of fact, reliability of the heat capacity values of crystalline/amorphous pharmaceutical compounds obtained from MTDSC measurements is frequently questionable. It is not intention of this paper to improve theoretical background on the use of MTDSC for the heat capacity measurements, but practical procedure to improve reliability of the experimental values for both amorphous and crystalline samples is introduced.
Experimental
Materials Acetaminophen (AAP) and indomethacin (IMC) were supplied from MP Biomedicals (Solon, OH, U.S.A.) and Wako Pure Chemical Industries, Ltd. (Osaka, Japan), respectively. Tri-O-methyl-β-cyclodextrin (MCD) was obtained from Nacalai Tesque (Kyoto, Japan). These model compounds were selected because reliable heat capacity literature data was available. All the reagents were used as supplied.
Differential Scanning Calorimetry (DSC) DSC measurements were performed on a DSC Q2000 (TA Instruments, New Castle, DE, U.S.A.) in the modulated mode by heating the sample (1-20 mg) in a sealed T-zero aluminum pan at 1-2°C/min with a 20-120 s period and 0.2-5°C amplitude after the quenching procedure as described later. Further general information on the modulated DSC measurements can be found in literature. [8] [9] [10] [11] [12] [13] The instrument was periodically calibrated with indium and sapphire. Nitrogen was supplied as an inert gas at a flow rate of 50 mL/min. All the measurements were repeated at least ten times to investigate reproducibility.
Thermal Stability of Model Compounds Thermal stability of each drug was investigated using thermogravimetry (TG) analysis on Rigaku Thermo plus TG8120 (Rigaku, Regular Article * To whom correspondence should be addressed. e-mail: kawakami.kohsaku@nims.go.jp
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Tokyo, Japan) and high-performance liquid chromatography (HPLC). TG analysis was made up to melting temperatures to observe weight loss due to decomposition and sublimation. Because thermal stability of AAP was anticipated in the TG study, it was annealed at 200°C on DSC and dissolved by ethanol, then subjected to HPLC analysis on a Shimadzu Prominence (Shimadzu, Kyoto, Japan) equipped with a Cosmosil 5C18-AR-II (150 mmL×5.0 mm, i.d., Nacalai Tesque, Kyoto, Japan) with a flow rate of 1 mL/min. The column was equilibrated by acetonitrile-water= 5 : 95 and measurements were done with this mobile phase for 10 min, followed by a gradual change to 100 : 0 over 40 min and elution by acetonitrile for 10 min. Detection wavelength and injection volume were 210 nm and 2 µL, respectively.
Results and Discussion

Thermal Stability of Model Compounds
In the following experiments, each drug is melted before measurement of heat capacity. If decomposition occurs, it should alter the heat capacity, and if sublimation happens, it may influence thermal contact of the sample by deposition on the lid and side walls of the sample pan. TG analysis revealed that weight loss during the heating up to the melting temperature was below 0.1% for IMC and MCD. Thus, these compounds were regarded to be stable at their melting points. Adsorbed water was removed in a stream of nitrogen before the measurements. AAP exhibited 0.2% weight loss by 200°C. However, HPLC analysis showed that there was no growth of the impurity peaks in the chromatogram during the 10-min annealing at the melting temperature. Therefore, thermal degradation during the melt-quench procedure was regarded to be negligible for all the model compounds used in this study.
Sample Preparation Procedure Various methods are available for preparing amorphous samples.
3) If the samples are thermally stable, the melt-quench procedure is the most suitable method for evaluating thermal characteristics of the amorphous state, because it can offer good thermal contact and the thermal history of the sample after the melting is well-controlled. Thus, amorphous samples were prepared by the melt-quench procedure. Figure 1 shows the effect of sample mass on the heat capacity for amorphous AAP. A small sample mass should be favorable from the viewpoint of temperature uniformity in the samples. However, if the sample mass was too small, the sample clustered at the edge of the Crystalline samples of the indicated amount in the figures were melted at 200°C in the sample pans, followed by cooling at 20°C/min to obtain the amorphous state. The measurement was made at 2°C/min with the 0.5°C of modulation amplitude and 60 s of modulation period. Ten measurements were made for each sample. Symbols represent literature values. 14) pans after the melting, which appeared to prevent acquisition of reproducible results. The reproducibility was improved with increasing sample mass when the amount was below 10 mg, and the value acquired agreed very well with that in the literature. 14) On the other hand, the heat capacity values decreased with increasing sample mass above 10 mg. This was most likely because of heterogeneity of temperature in the sample. Thus, the optimum sample mass was about 10 mg. Theoretical calculations indicated that the maximum thickness for the accurate heat capacity measurement of organic materials was about 0.6 mm, if the aluminum pan is regarded as a perfect conductor. 15) This provides a maximum sample mass of 12 mg under an assumption that the density is 1 g/cm 3 . Thus, the optimum value determined by our experiments, 10 mg, is reasonable based on the theoretical expectation.
Crystalline powder of AAP was carefully loaded into the pan at various sample masses and subjected to the heat capacity measurement to conclude that it was very difficult to obtain reproducible results using the powder samples. Even though samples were compressed into a disk shape to enhance thermal contact, reproducibility was barely improved. This observation was explained in terms of remaining gas between gaps in the solid samples that should influence thermal contact and the heat capacity. Thus, the powder samples were heated up to the melting temperature for condensation. Two strategies are available for obtaining crystalline samples. One is to melt the powder completely to obtain amorphous samples, and transform it into crystalline samples. However, some amorphous materials are too stable against crystallization. The other is to melt the powder only partially to allow recrystallization of the melted part. Since the remaining crystalline part plays a role as a template for subsequent crystallization, this procedure enables both rapid crystallization and control of the crystal form. Therefore, the latter procedure was employed to prepare condensed crystalline samples. Figure 2 shows the effect of the stop-temperature in the melting process during the first scan on the melting behavior of the second scan. If the samples were heated above 169.5°C, a crystallization exotherm was observed in the subsequent cooling scan, and the melting enthalpy in the second heating scan decreased significantly, indicating that the resultant solid should have very low crystallinity. Optimum stop-temperature was determined as 168.5°C for AAP based on the melting curve in the second heating scan, by which the largest and the sharpest peak was obtained. The peak area was slightly larger than that of the intact crystalline powder. Moreover, annealing The modulation period and the heating rate were 60 s and 2°C/min, respectively. For both measurements, the samples were prepared by the melt-quench procedure. The sample size was 10 mg. Ten measurements were made for each sample but only the representative curve for each condition is shown for simplicity. Symbols represent literature values. 14) of the crystallized samples for a few days improved reproducibility of the results presumably due to additional crystallization of the disordered portion. As a result, the melting enthalpy increased from 190.5 J/g (intact sample) to 193.3 J/g (recrystallized and annealed sample). The melting enthalpy of AAP has frequently been investigated and it is usually around 180°C. 16, 17) Because our value is almost the highest among the reported values, the crystallinity was assumed to be sufficiently high. Thus, the AAP crystals used for further studies were prepared using this procedure. Identical to the observation for the amorphous samples, reproducible results were obtained when the mass was about 10 mg for the crystalline samples, and the value agreed well with the literature value. Figure 3 shows the effect of the modulation period and heating rate on the heat capacity of amorphous AAP in the glass transition region. The heat capacity values decreased with increasing modulation period, and almost identical lines were obtained when the period was longer than 60 s. Thus, high heat capacity values under the short periodicity conditions were interpreted as a result of temperature heterogeneity in the samples due to too quick of a temperature change. The modulation amplitude did not have a great impact on the results except that too high of an amplitude decreased the clarity of the glass transition behavior, which appeared to be due to too quick temperature modulation as well. Note that this optimization procedure for the modulation condition was made for various sample masses. It was found that reproducible and reasonable values were obtained only at the optimum sample mass condition (10 mg) regardless of the modulation condition. It should also be stressed that effect of the modulation condition should depend on thermal lag of the instrument, although tendency of the observation is expected to be general.
18)
Optimization of Temperature-Modulation Condition
The same observation was made for AAP crystals as shown in Fig. 4 . Since there are no transition regions for the crystalline samples, the observation was not as sensitive to the modulation condition as the case for the amorphous samples.
Application to Other Compounds The same optimization procedure was applied to IMC and MCD for measuring their heat capacities in both crystalline and amorphous states. The amorphous IMC was obtained by melting the crystal at 180°C, and the crystalline IMC was acquired by partially melting the crystal at 160.5°C. The optimum sample amount was 10 mg for both cases. Although IMC has three crystal forms, the partial melting procedure provided the most stable form, the γ form, in a reproducible manner. Note that the intact crystal had the same crystal form. The optimum modulation conditions were the same as those for AAP. The obtained heat capacities are shown in Fig. 5 , which agreed very well with the literature values.
19) The amorphous MCD was obtained by melting the crystal at 180°C, and the crystalline MCD was manufactured by partially melting the crystal at 158.5°C, to find that the optimum condition for the heat capacity measurements appeared to be universal at least for organic low-molecular-weight compounds. Thus, the minimum requirement for the compounds to enable precise heat capacity measurement on MTDSC is the applicability of the melt-quench procedure to obtain condensed samples. In other words, the degradation The detailed conditions were the same as those for the amorphous AAP (Fig. 3) . The crystalline AAP was prepared by the partial melting procedure as described in the text. The circles and triangles represent heat capacity values in literature for amorphous and crystalline states, respectively. 19, 20) The corresponding lines are the experimental results obtained in our study. The sample preparation and the measurement conditions were the same as those for AAP with the exception of the melting temperatures. temperature must be sufficiently higher than the melting temperature. Also, if the compound has low glass-forming ability, the heat capacity value of the amorphous state is not available, since it crystallizes during the cooling or subsequent heating process. 21, 22) Volatile compounds are not suitable for the meltquench procedure, because the sample may be deposited on the lid and side walls of the pan. Also, since accurate weight values are required for the estimation of the heat capacity values, much care is required for hygroscopic compounds. Although some powder characteristics, including porosity, particle size, and density are important parameters that influence the measured heat capacity values, those contributions are less significant compared to the melting procedure in the DSC pan. The procedure presented in this paper should make a great contribution for obtaining basic thermodynamic information of various organic materials.
Conclusion
A protocol to determine accurate heat capacity values of pharmaceutical compounds using MTDSC was presented. Amorphous samples were prepared by a melt-quench procedure in the sample pan for enhancing thermal contact. Crystalline samples were prepared by partially melting the powder sample. Optimum sample mass was about 10 mg for both states, which agreed well with theoretical expectations. Optimum modulation period was in the range of 60 s and 90 s, to which the ramp rates of 2°C/min and 1°C/min, respectively, were applied. The ramp amplitude was less significant in the evaluation. This information should be helpful for comprehending basic characteristics of pharmaceutical compounds.
